000 | 01939 a2200493 4500 | ||
---|---|---|---|
005 | 20250514063436.0 | ||
264 | 0 | _c20030501 | |
008 | 200305s 0 0 eng d | ||
022 | _a1521-6616 | ||
024 | 7 |
_a10.1016/s1521-6616(02)00023-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGarcia, Yvonne R | |
245 | 0 | 0 |
_aMyocyte production of nitric oxide in response to AChR-reactive antibodies in two inbred rat strains may influence disease outcome in experimental myasthenia gravis. _h[electronic resource] |
260 |
_bClinical immunology (Orlando, Fla.) _cFeb 2003 |
||
300 |
_a116-26 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAntibody Specificity |
650 | 0 | 4 |
_aAutoantibodies _ximmunology |
650 | 0 | 4 |
_aCells, Cultured _xmetabolism |
650 | 0 | 4 |
_aClone Cells _xmetabolism |
650 | 0 | 4 |
_aEnzyme Induction _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aImmunization, Passive |
650 | 0 | 4 |
_aLysine _xanalogs & derivatives |
650 | 0 | 4 |
_aMuscle Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aMuscle, Skeletal _xmetabolism |
650 | 0 | 4 |
_aMyasthenia Gravis, Autoimmune, Experimental _xgenetics |
650 | 0 | 4 |
_aNitric Oxide _xbiosynthesis |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred Lew |
650 | 0 | 4 | _aRats, Inbred WF |
650 | 0 | 4 |
_aReceptors, Cholinergic _ximmunology |
650 | 0 | 4 | _aTorpedo |
700 | 1 | _aPothitakis, Jennifer C | |
700 | 1 | _aKrolick, Keith A | |
773 | 0 |
_tClinical immunology (Orlando, Fla.) _gvol. 106 _gno. 2 _gp. 116-26 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1521-6616(02)00023-2 _zAvailable from publisher's website |
999 |
_c12465335 _d12465335 |